Keybanc maintains FIGS at Overweight, raises price target to $27 from $20

Keybanc maintained its Overweight rating on FIGS and raised its price target to $27 from $20, suggesting a 33.6% upside from the Nov 5 close of $20.21. Recent analyst price targets for FIGS range from $24 to $25.

Original reporting
Published Nov 6, 2026, 2:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keybanc maintains FIGS at Overweight, raises price target to $27 from $20 — source image
Decision brief

The 30-second read

$FIGSBullishMed
01

Why it matters

The higher target may attract new buyers and support price gains.

02

Market read

Analyst upgrade provides a fresh catalyst for FIGS, modestly relevant to traders.

03

What to watch

Potential execution risks in FIGS' product rollout and competitive pressure.

Relevance 6/10Novelty 5/10Timing: today

Background

Keybanc's analyst note updates FIGS' valuation.

Company-level read

Ticker impact

$FIGSBullishHigh confidence
Context

Keybanc raised its price target for FIGS to $27 from $20, indicating a fresh bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target increase of 35% signals improved expectations, prompting buying interest.

Market effects

May lift sentiment in the health‑tech sector.

U.S. market focus, limited broader impact.

Low

Counterpoint

Target raise could be premature if growth expectations are not met.

Key entities

  • Keybanc

    Equity research firm issuing the target raise.

  • FIGS

    Health‑tech apparel company.

Related articles

$FIGSHighAI 8/10

Cantor Fitzgerald initiates Figs stock with overweight rating

Cantor Fitzgerald initiated coverage on Figs Inc. (NYSE:FIGS) with an overweight rating and a $25.00 price target. The stock trades at $21.58 with a $3.58B market cap. Figs reported Q3 2026 core scrubs sales of $191M, up 26%, and raised fiscal 2026 sales guidance to 23.5%. The company's gross profit margin is 67.73%, and adjusted EBITDA margin is projected to rise to 18.4% by fiscal 2028. FIGS shares declined in after-hours trading despite beating earnings expectations.

$FIGSHighAI 8/10

Why Figs Stock Popped Today

Figs (FIGS) stock rose 7.8% after Q3 earnings beat estimates, with revenue up 26% YoY to $190.7M and EPS at $0.10. Core scrubs sales grew 24%, while non-scrubwear and international sales saw faster growth. Profit margins expanded to 10.1%. CEO Trina Spear expects momentum into 2027, but Q4 growth forecast is slower at 15%.

$FIGSMed

What FIGS (FIGS) Said on Its Q3 Earnings Call

FIGS reported Q3 revenue of $190.7M, up 21% in the U.S. and 51% internationally. Gross margin was 69.3%, down 60 bps but above expectations. Adjusted EBITDA margin rose to 16.5%. The company raised its full-year 2026 revenue growth forecast to 23.5% and adjusted its margin outlooks. FIGS faces supply chain challenges but expects to expand production capacity in Indonesia by 2027. Inventory fell 20% YoY to $121.3M.

$FIGSHighAI 8/10

FIGS Inc (FIGS) (Q3 2026) Earnings Call Highlights: Revenue Surges 26% as International

FIGS Inc reported Q3 2026 revenue of $190M, up 26% YoY, beating guidance despite supply constraints. CEO Trina Spear highlighted strong US growth, driven by e-commerce and hubs/Teams. CFO Sarah Altred cited revenue leverage, marketing efficiencies, and improved product mix for margin expansion. The company expects continued growth in 2027, with international markets and new categories like 'the Charmacy' as key drivers.